Closed calls
| Company | Drugs | Class | Closing date |
| Biothera | Imprime PGG | Innate Immune modulator | 16 February 2015 |
| Verastem | VS-6063 | Focal Adhesion Kinase (FAK) inhibitor | 16 February 2015 |
| MedImmune | MEDI0639 | Anti-DLL4 mAb | 16 July 2014 |
| MEDI3617 | Anti-ANG2 mAb | 16 July 2014 | |
| Astex | AT13387 |
Non-ansamycin HSP90 inhibitor
Second generation hypomethylating agent |
30 May 2014 |
| AZD1208 | PIM inhibitor | 25 June 2014 | |
| AZD1775 | Wee1 inhibitor | ||
| AZD2014 | mTOR inhibitor | ||
| Selumetinib | MEK inhibitor | ||
| AZD9291 | EGFR sensitising and T790M Resistance Mutations Inhibitor | ||
| AZD9150 | STAT3rx antisense oligonucleotide | ||
| Gefitinib (Iressa®) | EGFR inhibitor | ||
| AZD5363 | AKT inhibitor | ||
| AZD6738 | ATR inhibitor | ||
| AZD8186 | PI3Kβ/δ selective inhibitor | ||
| Volitinib | cMET inhibitor | ||
| VandetanibTM(Caprelsa®) | RET, EGFR, VEGF inhibitor | ||
| Olaparib | PARP inhibitor | ||
| Lilly | LY2940680 | Hedgehog inhibitor | 7 February 2014 |